Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cross Infection | 6 | 2014 | 141 | 1.040 |
Why?
|
| Disease Outbreaks | 7 | 2017 | 152 | 0.840 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2011 | 101 | 0.580 |
Why?
|
| Adenovirus Infections, Human | 2 | 2007 | 3 | 0.520 |
Why?
|
| Influenza, Human | 3 | 2011 | 327 | 0.490 |
Why?
|
| Population Surveillance | 2 | 2011 | 219 | 0.470 |
Why?
|
| Diarrhea | 2 | 2011 | 180 | 0.460 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 3 | 2016 | 9 | 0.410 |
Why?
|
| Infection Control | 2 | 2015 | 114 | 0.380 |
Why?
|
| Clostridium Infections | 1 | 2011 | 120 | 0.360 |
Why?
|
| Foodborne Diseases | 1 | 2008 | 8 | 0.330 |
Why?
|
| Adenoviruses, Human | 2 | 2007 | 41 | 0.280 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 32 | 0.280 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2006 | 61 | 0.280 |
Why?
|
| Child, Preschool | 7 | 2017 | 3578 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 505 | 0.240 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 251 | 0.230 |
Why?
|
| Infant | 5 | 2017 | 3003 | 0.220 |
Why?
|
| Hospitals, Chronic Disease | 1 | 2001 | 2 | 0.210 |
Why?
|
| Child | 6 | 2017 | 6776 | 0.180 |
Why?
|
| Adolescent | 7 | 2017 | 8849 | 0.180 |
Why?
|
| Coronavirus Infections | 2 | 2015 | 294 | 0.180 |
Why?
|
| Herpesvirus 2, Human | 2 | 1996 | 44 | 0.170 |
Why?
|
| Kaposi Varicelliform Eruption | 2 | 2008 | 6 | 0.170 |
Why?
|
| Herpesvirus 1, Human | 3 | 1996 | 242 | 0.170 |
Why?
|
| Smallpox Vaccine | 2 | 2008 | 12 | 0.170 |
Why?
|
| Feces | 2 | 2011 | 306 | 0.170 |
Why?
|
| Illinois | 2 | 2011 | 459 | 0.160 |
Why?
|
| Tularemia | 1 | 1997 | 8 | 0.160 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1997 | 8 | 0.160 |
Why?
|
| Enterovirus D, Human | 1 | 2017 | 4 | 0.160 |
Why?
|
| Pneumonia, Bacterial | 1 | 1997 | 28 | 0.160 |
Why?
|
| Enterovirus Infections | 1 | 2017 | 40 | 0.160 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 104 | 0.150 |
Why?
|
| Chicago | 3 | 2011 | 1366 | 0.140 |
Why?
|
| Health Care Surveys | 2 | 2008 | 277 | 0.140 |
Why?
|
| Travel | 2 | 2015 | 67 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2016 | 104 | 0.140 |
Why?
|
| Viral Envelope Proteins | 1 | 1995 | 96 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 268 | 0.130 |
Why?
|
| Pandemics | 2 | 2011 | 704 | 0.130 |
Why?
|
| Hospitals | 2 | 2011 | 276 | 0.130 |
Why?
|
| Long-Term Care | 2 | 2007 | 60 | 0.120 |
Why?
|
| Adult | 9 | 2016 | 25287 | 0.120 |
Why?
|
| Family Health | 2 | 2011 | 162 | 0.120 |
Why?
|
| Young Adult | 4 | 2011 | 5883 | 0.110 |
Why?
|
| Humans | 18 | 2017 | 84493 | 0.110 |
Why?
|
| Age Distribution | 1 | 2011 | 204 | 0.100 |
Why?
|
| Schools | 1 | 2011 | 65 | 0.100 |
Why?
|
| Patient Transfer | 1 | 2011 | 91 | 0.100 |
Why?
|
| Male | 10 | 2017 | 40460 | 0.100 |
Why?
|
| Disease Transmission, Infectious | 1 | 2011 | 57 | 0.090 |
Why?
|
| Nursing Homes | 1 | 2011 | 108 | 0.090 |
Why?
|
| Female | 10 | 2017 | 43911 | 0.090 |
Why?
|
| Fomites | 1 | 2008 | 2 | 0.090 |
Why?
|
| Vaccinia virus | 1 | 2008 | 19 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 372 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2011 | 2336 | 0.090 |
Why?
|
| Escherichia coli O157 | 1 | 2008 | 1 | 0.080 |
Why?
|
| Salmonella | 1 | 2008 | 14 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2011 | 308 | 0.080 |
Why?
|
| Logistic Models | 1 | 2011 | 1168 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2017 | 4091 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2011 | 468 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2011 | 500 | 0.080 |
Why?
|
| Health Facilities | 1 | 2007 | 31 | 0.080 |
Why?
|
| Middle Aged | 5 | 2014 | 24751 | 0.080 |
Why?
|
| Incidence | 1 | 2011 | 1559 | 0.080 |
Why?
|
| Aged | 3 | 2011 | 18159 | 0.070 |
Why?
|
| Health Personnel | 2 | 2014 | 193 | 0.070 |
Why?
|
| Antibodies, Viral | 3 | 2014 | 293 | 0.070 |
Why?
|
| Heparin | 2 | 1996 | 174 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 6457 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 261 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 574 | 0.060 |
Why?
|
| Angiostrongylus cantonensis | 1 | 2002 | 1 | 0.060 |
Why?
|
| Strongylida Infections | 1 | 2002 | 6 | 0.060 |
Why?
|
| Meningitis, Aseptic | 1 | 2002 | 8 | 0.050 |
Why?
|
| Vero Cells | 3 | 1996 | 100 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2011 | 8152 | 0.050 |
Why?
|
| Serotyping | 2 | 1996 | 28 | 0.040 |
Why?
|
| Francisella tularensis | 1 | 1997 | 9 | 0.040 |
Why?
|
| DNA, Viral | 2 | 2008 | 263 | 0.040 |
Why?
|
| Ohio | 1 | 2017 | 36 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 1997 | 87 | 0.040 |
Why?
|
| Pharynx | 1 | 2017 | 46 | 0.040 |
Why?
|
| United States | 4 | 2015 | 6474 | 0.040 |
Why?
|
| NADPH Oxidases | 1 | 1997 | 81 | 0.040 |
Why?
|
| Nose | 1 | 2017 | 95 | 0.040 |
Why?
|
| Medical Records | 1 | 2017 | 118 | 0.040 |
Why?
|
| Saudi Arabia | 1 | 2016 | 16 | 0.040 |
Why?
|
| Pediatrics | 1 | 2001 | 342 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 105 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 1997 | 253 | 0.040 |
Why?
|
| Heparitin Sulfate | 1 | 1995 | 27 | 0.040 |
Why?
|
| Seasons | 1 | 2017 | 221 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 1995 | 75 | 0.040 |
Why?
|
| Neutrophils | 1 | 1997 | 302 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 1995 | 72 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 1995 | 81 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1995 | 198 | 0.030 |
Why?
|
| Africa, Western | 1 | 2015 | 10 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 812 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1997 | 887 | 0.030 |
Why?
|
| DNA Primers | 1 | 1995 | 539 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 242 | 0.030 |
Why?
|
| Jordan | 1 | 2014 | 10 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2014 | 53 | 0.030 |
Why?
|
| Species Specificity | 1 | 1995 | 677 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 1041 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 3025 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 1997 | 716 | 0.030 |
Why?
|
| Hospitalization | 1 | 2017 | 817 | 0.030 |
Why?
|
| Base Sequence | 1 | 1995 | 2321 | 0.030 |
Why?
|
| Respiratory Protective Devices | 1 | 2011 | 2 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2011 | 46 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2011 | 62 | 0.020 |
Why?
|
| Asthma | 1 | 2017 | 940 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 2820 | 0.020 |
Why?
|
| Isoindoles | 1 | 2008 | 13 | 0.020 |
Why?
|
| Plasma | 1 | 2008 | 50 | 0.020 |
Why?
|
| Organophosphonates | 1 | 2008 | 50 | 0.020 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 45 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 153 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2008 | 64 | 0.020 |
Why?
|
| Benzamides | 1 | 2008 | 224 | 0.020 |
Why?
|
| Cytosine | 1 | 2008 | 126 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2008 | 173 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1222 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 925 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 448 | 0.020 |
Why?
|
| Animals | 4 | 2002 | 26197 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 1996 | 403 | 0.020 |
Why?
|
| Jamaica | 1 | 2002 | 5 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 2002 | 11 | 0.010 |
Why?
|
| Headache | 1 | 2002 | 72 | 0.010 |
Why?
|
| Eosinophilia | 1 | 2002 | 82 | 0.010 |
Why?
|
| Intracranial Hypertension | 1 | 2002 | 48 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2002 | 257 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 1995 | 19 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1995 | 20 | 0.010 |
Why?
|
| Carbohydrate Conformation | 1 | 1995 | 18 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 2719 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 388 | 0.010 |
Why?
|
| Virion | 1 | 1995 | 58 | 0.010 |
Why?
|
| Kinetics | 1 | 1995 | 1506 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1995 | 660 | 0.010 |
Why?
|
| Risk Factors | 1 | 2002 | 5313 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1955 | 0.010 |
Why?
|
| Cell Line | 1 | 1995 | 2452 | 0.010 |
Why?
|